A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Atherothrombotic Diseases

Interventions

DRUG

BMS 986141

Two single doses BMS 986141 (days 1 and 13) and single daily doses Rifampin (days 7-22)

DRUG

Rifampin

Two single doses BMS 986141 (days 1 and 13) and single daily doses Rifampin (days 7-22)